Advertisement
  • Forward Look

    Cancer Screening: A Dose of Reality

    Q&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

    by Sue Rochman

  • Forward Look

    When Is “Cancer” Not Cancer?

    Does the word “cancer” discourage patients with very early disease from fully considering all their options?

    by Stephen Ornes

  • Forward Look

    The Avastin Roller Coaster

    Ups and downs keep coming for Avastin as studies report on its effects for different cancers.

    by Sue Rochman

  • Clinical Trials Game-Changer?

    A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?

    by Sue Rochman

  • Cancer In America

    Standard of Care

    Research suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?

    by Charlotte Huff

  • The HPV Cancer Connection: Take 2

    New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.

    by Alanna Kennedy-Gorman

  • Healthy Habits

    Just Another Meatless Monday

    Make room for tasty vegetarian dishes in your weekly menu.

    by Alanna Kennedy-Gorman

  • The Birth of a Targeted Therapy

    A serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.

    by Jocelyn Selim

  • The Wait for a Match

    Many patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.

    by Karen Patterson

  • Global Report

    Stark Realities in Zambia

    An American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.

    by Cynthia Ryan